Publications by authors named "Reshmi Parameswaran"

Claim this Profile
C
Chimeric antigen receptor-engineered (CAR)-T cell therapy for metastatic prostate cancer.
Leah Tharian, Shiv Verma, Daniel Feinberg, Reshmi Parameswaran, Sanjay Gupta

Cancer Lett· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell activating factor plays a critical role in CAR-T cell-associated cytokine release syndrome.
Claire Fritz, Leland Metheny, David Wald, Paolo Caimi, Reshmi Parameswaran

bioRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipodystrophy and recovery are mediated by the Wnt/lipogenesis axis during skin fibrosis.
Suneeti Madhavan, Piper Moore, Rohan Varshney, Miles Montegut, Qiannan Ma, Reshmi Parameswaran

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B Cell Activating Factor Induces Drug Resistance in Hairy Cell Leukemia Variant.
Claire Fritz, Daniel Feinberg, Akshaya Radhakrishnan, Kayla Klatt, E Ricky Chan, Reshmi Parameswaran

Biomedicines· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy.
Vinayak Uppin, Hunter Gibbons, Marissa Troje, Daniel Feinberg, Beau R Webber, Reshmi Parameswaran

J Autoimmun· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell therapy for a rare disease- hairy cell leukemia variant.
Claire Fritz, Derek P Wong, Philip Rock, Richard Burack, Akshaya Radhakrishnan, Reshmi Parameswaran

Oncoimmunology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
p35 is a Crucial Player in NK-cell Cytotoxicity and TGFβ-mediated NK-cell Dysfunction.
Derek P Wong, Claire E Fritz, Daniel Feinberg, Alex Y Huang, Reshmi Parameswaran

Cancer Res Commun· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of O-GlcNAcylation Decreases the Cytotoxic Function of Natural Killer Cells.
Daniel Feinberg, Parameswaran Ramakrishnan, Derek P Wong, Abhishek Asthana, Reshmi Parameswaran

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers.
Derek P Wong, Nand K Roy, Keman Zhang, Anusha Anukanth, Abhishek Asthana, Reshmi Parameswaran

Nat Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NF-κB c-Rel Is Dispensable for the Development but Is Required for the Cytotoxic Function of NK Cells.
Yorleny Vicioso, Derek P Wong, Nand K Roy, Nayanika Das, Keman Zhang, Parameswaran Ramakrishnan, Reshmi Parameswaran

Front Immunol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BAFF receptor antibody for mantle cell lymphoma therapy.
Keman Zhang, Nand K Roy, Yorleny Vicioso, Janghee Woo, Rose Beck, Reshmi Parameswaran

Oncoimmunology· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia.
Yorleny Vicioso, Hermann Gram, Rose Beck, Abhishek Asthana, Keman Zhang, Reshmi Parameswaran

Cancer Immunol Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia.
Bradley Ryva, Keman Zhang, Abhishek Asthana, Derek Wong, Yorleny Vicioso, Reshmi Parameswaran

Front Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.
Abhishek Asthana, Parameswaran Ramakrishnan, Yorleny Vicioso, Keman Zhang, Reshmi Parameswaran

Mol Cancer Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency of Nuclear Factor-κB c-Rel Accelerates the Development of Autoimmune Diabetes in NOD Mice.
Parameswaran Ramakrishnan, Mary A Yui, Jeffrey A Tomalka, Devdoot Majumdar, Reshmi Parameswaran

Diabetes· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repression of GSK3 restores NK cell cytotoxicity in AML patients.
Reshmi Parameswaran, Parameswaran Ramakrishnan, Stephen A Moreton, Zhiqiang Xia, Yongchun Hou

Nat Commun· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effector-mediated eradication of precursor B acute lymphoblastic leukemia with a novel Fc-engineered monoclonal antibody targeting the BAFF-R.
Reshmi Parameswaran, Min Lim, Fei Fei, Hisham Abdel-Azim, Anna Arutyunyan

Mol Cancer Ther· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia.
Reshmi Parameswaran, Min Lim, Anna Arutyunyan, Hisham Abdel-Azim, Christian Hurtz

J Exp Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.
Yao-Te Hsieh, Eun Ji Gang, Huimin Geng, Eugene Park, Sandra Huantes, Reshmi Parameswaran

Blood· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional receptor for B-cell-activating factor is expressed on human acute lymphoblastic leukemias.
Reshmi Parameswaran, Markus Müschen, Yong-Mi Kim, John Groffen, Nora Heisterkamp

Cancer Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tolerogenic peptide down-regulates mature B cells in bone marrow of lupus-afflicted mice by inhibition of interleukin-7, leading to apoptosis.
Hava Ben-David, Amir Sharabi, Reshmi Parameswaran, Heidy Zinger, Edna Mozes

Immunology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
Reshmi Parameswaran, Hava Ben David, Amir Sharabi, Heidy Zinger, Edna Mozes

Clin Immunol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the bone marrow with activin A-overexpressing embryonic multipotent stromal cells specifically modifies B lymphopoiesis.
Reshmi Parameswaran, Vered Morad, Ayelet Laronne, Liat Rousso-Noori, Nir Shani

Stem Cells Dev· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activin betaA in term placenta and its correlation with placental inflammation in parturients having epidural or systemic meperidine analgesia: a randomized study.
Shmuel Evron, Reshmi Parameswaran, Dov Zipori, Tiberiu Ezri, Oscar Sadan

J Clin Anesth· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mesenchymal stroma negatively regulates B cell lymphopoiesis through the expression of activin A.
Tsipi Shoham, Reshmi Parameswaran, Yaron Shav-Tal, Mira Barda-Saad, Dov Zipori

Ann N Y Acad Sci· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis